17:22 EST ARS Pharmaceuticals (SPRY) files automatic mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRY:
- ARS Pharmaceuticals launches neffyinSchools program
- ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
- ARS Pharmaceuticals Highlights Success and Plans for 2025
- ARS Pharmaceuticals reports 2025 key strategic priorities
- ARS Pharmaceuticals reports preliminary Q4 neffy revenue $6.5M
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue